Hayes Christopher G.
SEC insider (Form 3/4/5 filer). CIK 0001805359. CHIEF LEGAL OFFICER at Verrica Pharmaceuticals Inc. (VRCA). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 17, 2025. Located in WEST CHESTER, PA.
Companies Hayes Christopher G. has filed insider reports for
- Verrica Pharmaceuticals Inc. (VRCA): Officer, CHIEF LEGAL OFFICER
Hayes Christopher G.
CIK: 0001805359
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Verrica Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 17, 2025VRCA
Verrica Pharmaceuticals Inc.
SaleDirect4.3K shares at avg. $0.65$3K - Mar 14, 2025VRCA
Verrica Pharmaceuticals Inc.
AwardDirectEmployee Stock Option (right to buy)
250K shares- - Oct 9, 2024VRCA
Verrica Pharmaceuticals Inc.
AwardDirectEmployee Stock Option (right to buy)
50K shares- - Aug 24, 2023VRCA
Verrica Pharmaceuticals Inc.
AwardDirect150K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 17, 2025 | VRCA Verrica Pharmaceuticals Inc. | Sale | 4,315 | $0.65 | $2,805 | Direct |
| Mar 14, 2025 | VRCA Verrica Pharmaceuticals Inc. | Award Employee Stock Option (right to buy) | 250,000 | - | - | Direct |
| Oct 9, 2024 | VRCA Verrica Pharmaceuticals Inc. | Award Employee Stock Option (right to buy) | 50,000 | - | - | Direct |
| Aug 24, 2023 | VRCA Verrica Pharmaceuticals Inc. | Award | 150,000 | - | - | Direct |
1-4 of 4 transactions